Top

Published in:

01-02-2014 | Mini Review

Sarcopenic obesity in aging population: current status and future directions for research

Author: Katsuhiko Kohara

Published in: Endocrine | Issue 1/2014

Abstract

The combination of sarcopenia and obesity, an age-related change in body composition, is a concern in the aged society. Sarcopenic obesity is not the combination of two conditions, but is more related to cardio-metabolic and functional abnormalities. Sarcopenic obesity is associated with more physical functional decline than simple obesity. Sarcopenic obesity may be more insulin resistant, and have a higher risk for metabolic syndrome and atherosclerosis than simple obesity. However, the prevalence of sarcopenic obesity differs substantially among studies because of the lack of a standard definition. For further understanding of the pathophysiological role of sarcopenic obesity, a standardized definition for both sarcopenia and obesity is necessary.

C. Dutta, Significance of sarcopenia in the elderly. J. Nutr. 127(5 Suppl), 992S–993S (1997)PubMed

J.G. Ryall, J.D. Schertzer, G.S. Lynch, Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9, 213–228 (2008)PubMedCrossRef

J.M. Kinney, Nutritional frailty, sarcopenia and falls in the elderly. Curr. Opin. Clin. Nutr. Metab. Care. 7, 15–20 (2004)PubMedCrossRef

A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, European working group on sarcopenia in older people. sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age. Ageing. 39, 412–423 (2010)PubMedCrossRef

R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, A.B. Newman, G. Abellan van Kan, S. Andrieu, J. Bauer, D. Breuille, T. Cederholm, J. Chandler, C. De Meynard, L. Donini, T. Harris, A. Kannt, F. Keime Guibert, G. Onder, D. Papanicolaou, Y. Rolland, D. Rooks, C. Sieber, E. Souhami, S. Verlaan, M. Zamboni, Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249–256 (2011)PubMedCrossRef

C.M. Prado, J.C. Wells, S.R. Smith, B.C. Stephan, M. Siervo, Sarcopenic obesity: a critical appraisal of the current evidence. Clin. Nutr. 31, 583–601 (2012)PubMedCrossRef

M. Zamboni, G. Mazzali, F. Fantin, A. Rossi, V. Di Francesco, Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18, 388–395 (2008)PubMedCrossRef

L.J. Dominguez, M. Barbagallo, The cardiometabolic syndrome and sarcopenic obesity in older persons. J. Cardiometab. Syndr. 2, 183–189 (2007)PubMedCrossRef

S. Stenholm, T.B. Harris, T. Rantanen, M. Visser, S.B. Kritchevsky, L. Ferrucci, Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care. 11, 693–700 (2008)PubMedCentralPubMedCrossRef

10.

J.P. Gumucio, C.L. Mendias, Atrogin-1, MuRF-1, and sarcopenia. Endocrine 43, 12–21 (2013)PubMedCrossRef

11.

N. Mangner, Y. Matsuo, G. Schuler, V. Adams, Cachexia in chronic heart failure: endocrine determinants and treatment perspectives. Endocrine 43, 253–265 (2013)PubMedCrossRef

12.

A.J. Cruz-Jentoft, F. Landi, E. Topinková, J.P. Michel, Understanding sarcopenia as a geriatric syndrome. Curr. Opin. Clin. Nutr. Met. Care. 13, 1–7 (2010)CrossRef

13.

S.W. Park, B.H. Goodpaster, E.S. Strotmeyer, L.H. Kuller, R. Broudeau, C. Kammerer, N. de Rekeneire, T.B. Harris, A.V. Schwartz, F.A. Tylavsky, Y.W. Cho, A.B. Newman, Health, Aging, and body composition study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 30, 1507–1512 (2007)PubMedCrossRef

14.

S.W. Park, B.H. Goodpaster, J.S. Lee, L.H. Kuller, R. Boudreau, N. de Rekeneire, T.B. Harris, S. Kritchevsky, F.A. Tylavsky, M. Nevitt, Y.W. Cho, A.B. Newman, Health, aging, and body composition study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 32, 1993–1997 (2009)PubMedCrossRef

15.

C.G. Lee, E.J. Boyko, E.S. Strotmeyer, C.E. Lewis, P.M. Cawthon, A.R. Hoffman, S.A. Everson-Rose, E. Barrett-Connor, E.S. Orwoll, Osteoporotic fractures in men study research group. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J. Am. Geriatr. Soc. 59, 1217–1224 (2011)PubMedCentralPubMedCrossRef

16.

H.K. Vincent, S.N. Raiser, K.R. Vincent, The aging musculoskeletal system and obesity-related considerations with exercise. Ageing. Res. Rev. 11,361–373 (2012)

17.

C.G. Lee, E.J. Boyko, E. Barrett-Connor, I. Miljkovic, A.R. Hoffman, S.A. Everson-Rose, C.E. Lewis, P.M. Cawthon, E.S. Strotmeyer, E.S. Orwoll, Osteoporotic Fractures in Men (MrOS) Study Research Group. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care. 34, 2381–2386 (2011)PubMedCrossRef

18.

P. Srikanthan, A.L. Hevener, A.S. Karlamangla, Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the national health and nutrition examination survey III. PLoS ONE 5, e10805 (2010)PubMedCentralPubMedCrossRef

19.

T.N. Kim, M.S. Park, K.I. Lim, S.J. Yang, H.J. Yoo, H.J. Kang, W. Song, J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi, K.M. Choi, Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean sarcopenic obesity study (KSOS). Diabetes Res. Clin. Pract. 93, 285–291 (2011)PubMedCrossRef

20.

R. Oliveira, M. Bottaro, J. Junior, P. Farinatti, L. Bezerra, R. Lima, Identification of sarcopenic obesity in postmenopausal women: a cut off proposal. Braz. J. Med. Biol. Res. 44, 1171–1176 (2011)PubMedCrossRef

21.

T.W. Auyeung, J.S. Lee, J. Leung, T. Kwok, J. Woo, Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults-an alternative measurement of sarcopenia and sarcopenic obesity. Age (2013) (in press)

22.

R.N. Baumgartner, K.M. Koehler, D. Gallagher, L. Romero, S.B. Heymsfield, R.R. Ross, P.J. Garry, R.D. Lindeman, Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147, 755–763 (1998)PubMedCrossRef

23.

R.N. Baumgartner, Body composition in healthy aging. Ann. N. Y. Acad. Sci. 904, 437–448 (2000)PubMedCrossRef

24.

A.B. Newman, V. Kupelian, M. Visser, E. Simonsick, B. Goodpaster, M. Nevitt, S.B. Kritchevsky, F.A. Tylavsky, S.M. Rubin, T.B. Harris, Health ABC study investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J. Am. Geriatr. Soc. 51, 1602–1609 (2003)PubMedCrossRef

25.

R.N. Baumgartner, S.J. Wayne, D.L. Waters, I. Janssen, D. Gallagher, J.E. Morley, Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995–2004 (2004)PubMedCrossRef

26.

C.M. Prado, J.R. Lieffers, L.J. McCargar, T. Reiman, M.B. Sawyer, L. Martin, V.E. Baracos, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 9, 629–635 (2008)PubMedCrossRef

27.

D.R. Bouchard, I. Janssen, Dynapenic-obesity and physical function in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 65, 71–77 (2010)PubMedCrossRef

28.

M.E. Levine, E.M. Crimmins, The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity 20, 2101–2106 (2012)PubMedCentralPubMedCrossRef

29.

K.K. Davison, E.S. Ford, M.E. Cogswell, W.H. Dietz, Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J. Am. Geriatr. Soc. 50, 1802–1809 (2002)PubMedCrossRef

30.

D.R. Bouchard, I.J. Dionne, M. Brochu, Sarcopenic/obesity and physical capacity in older men and women: data from the nutrition as a determinant of successful aging (NuAge)-the Quebec longitudinal study. Obesity 17, 2082–2088 (2009)PubMedCrossRef

31.

B. Sternfeld, L. Ngo, W.A. Satariano, I.B. Tager, Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am. J. Epidemiol. 156, 110–121 (2002)PubMedCrossRef

32.

S. Stenholm, T. Rantanen, M. Heliovaara, S. Koskinen, The mediating role of C reactive protein and handgrip strength between obesity and walking limitation. J. Am. Geriatr. Soc. 56, 462–469 (2008)PubMedCrossRef

33.

Y. Rolland, V. Lauwers-Cances, C. Cristini, G. Abellan van Kan, I. Janssen, J.E. Morley, B. Vellas, Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) study. Am. J. Clin. Nutr. 89, 1895–1900 (2009)PubMedCrossRef

34.

M.A. Monteiro, R.C. Gabriel, M.F. Sousa, M.N. Castro, M.H. Moreira, Temporal parameters of the foot roll-over during walking: influence of obesity and sarcopenic obesity on postmenopausal women. Maturitas 67, 178–185 (2010)PubMedCrossRef

35.

M. Ochi, Y. Tabara, T. Kido, E. Uetani, N. Ochi, M. Igase, T. Miki, K. Kohara, Quadriceps sarcopenia and visceral obesity are risk factors for postural instability in the middle-aged to elderly population. Geriatr. Gerontol. Int. 10, 233–243 (2010)PubMedCrossRef

36.

M. Ochi, K. Kohara, Y. Tabara, T. Kido, E. Uetani, N. Ochi, M. Igase, T. Miki, Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 212, 327–332 (2010)PubMedCrossRef

37.

H. Honda, A.R. Qureshi, J. Axelsson, O. Heimburger, M.E. Suliman, P. Barany, P. Stenvinkel, B. Lindholm, Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am. J. Clin. Nutr. 86, 633–638 (2007)PubMed

38.

M. Cesari, S.B. Kritchevsky, R.N. Baumgartner, H.H. Atkinson, B.W. Penninx, L. Lenchik, S.L. Palla, W.T. Ambrosius, R.P. Tracy, M. Pahor, Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am. J. Clin. Nutr. 82, 428–434 (2005)PubMed

39.

A.M. Abbatecola, P. Chiodini, C. Gallo, E. Lakatta, K. Sutton-Tyrrell, F.A. Tylavsky, B. Goodpaster, N. de Rekeneire, A.V. Schwartz, G. Paolisso, T. Harris, Health ABC study. Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age 34, 469–478 (2012)PubMedCrossRef

40.

A. Kato, J. Ishida, Y. Endo, T. Takita, M. Furuhashi, Y. Maruyama, M. Odamaki, Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol. Dial. Transplant. 26, 1967–1976 (2011)PubMedCrossRef

41.

K. Kohara, M. Ochi, Y. Tabara, T. Nagai, M. Igase, T. Mik, Arterial stiffness in sarcopenic visceral obesity in the elderly: J-SHIPP study. Int. J. Cardiol. 158, 146–148 (2012)PubMedCrossRef

42.

H. Enoki, M. Kuzuya, Y. Masuda, Y. Hirakawa, M. Iwata, J. Hasegawa, S. Izawa, A. Iguchi, Anthropometric measurements of mid-upper arm as a mortality predictor for community-dwelling Japanese elderly: the Nagoya longitudinal study of frail elderly (NLS-FE). Clin. Nutr. 26, 597–604 (2007)PubMedCrossRef

43.

H. Sasaki, F. Kasagi, M. Yamada, S. Fujita, Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am. J. Med. 120, 337–342 (2007)PubMedCrossRef

44.

A.B. Newman, V. Kupelian, M. Visser, E.M. Simonsick, B.H. Goodpaster, S.B. Kritchevsky, F.A. Tylavsky, S.M. Rubin, T.B. Harris, Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J. Gerontol. A Biol. Sci. Med. Sci. 61, 72–77 (2006)PubMedCrossRef

45.

M. Cesari, M. Pahor, F. Lauretani, V. Zamboni, S. Bandinelli, R. Bernabei, J.M. Guralnik, L. Ferrucci, Skeletal muscle and mortality results from the InCHIANTI Study. J. Gerontol. A Biol. Sci. Med. Sci. 64, 377–384 (2009)PubMedCrossRef

46.

S. Lim, J.H. Kim, J.W. Yoon, S.M. Kang, S.H. Choi, Y.J. Park, K.W. Kim, J.Y. Lim, K.S. Park, H.C. Jang, Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on health and aging (KLoSHA). Diabetes Care 33, 1652–1654 (2010)PubMedCrossRef

47.

K.I. Lim, S.J. Yang, T.N. Kim, H.J. Yoo, H.J. Kang, W. Song, S.H. Baik, D.S. Choi, K.M. Choi, The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean sarcopenic obesity study (KSOS). Clin. Endocrinol. 73, 588–594 (2010)CrossRef

48.

C.W. Lu, K.C. Yang, H.H. Chang, L.T. Lee, C.Y. Chen, K.C. Huang, Sarcopenic obesity is closely associated with metabolic syndrome. Obes. Res. Clin. Pract. (2013) (in press)

49.

V. Messier, A.D. Karelis, M.E. Lavoie, M. Brochu, M. Faraj, I. Strychar, R. Rabasa-Lhoret, Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Appl. Physiol. Nutr. Metabol. 34, 18–24 (2009)CrossRef

50.

G. Sweeney, Cardiovascular effects of leptin. Nat. Rev. Cardiol. 7, 22–29 (2010)PubMedCrossRef

51.

D.L. Waters, C.R. Qualls, R.I. Dorin, J.D. Veldhuis, R.N. Baumgartner, Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. J. Gerontol. A Biol. Sci. Med. Sci. 63, 536–541 (2008)PubMedCrossRef

52.

K. Kohara, M. Ochi, Y. Tabara, T. Nagai, M. Igase, T. Miki, Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes. PLoS ONE 6, e24633 (2011)PubMedCentralPubMedCrossRef

53.

S.C. Forbes, J.P. Little, D.G. Candow, Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29–38 (2012)PubMedCrossRef

54.

Z. Li, D. Heber, Sarcopenic obesity in the elderly and strategies for weight management. Nutr. Rev. 70, 57–64 (2012)

55.

M. Jacqmain, E. Doucet, J.P. Despres, C. Bouchard, A. Tremblay, Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am. J. Clin. Nutr. 77, 1448–1452 (2003)

56.

H. Shi, D. Dirienzo, M.B. Zemel, Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J. 15, 291–293 (2001)

57.

M.H. Seo, M.K. Kim, S.E. Park, E.J. Rhee, C.Y. Park, W.Y. Lee, K.H. Baek, K.H. Song, M.I. Kang, K.W. Oh, The association between daily calcium intake and sarcopenia in older, non-obese Korean adults: the fourth Korea national health and nutrition examination survey (KNHANES IV) 2009. Endocr. J. (2013) (in press)

58.

M.K. Kim, K.H. Baek, K.H. Song, M. Il Kang, C.Y. Park, W.Y. Lee, K.W. Oh, Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the fourth Korea national health and nutrition examination surveys (KNHANES IV) 2009. J. Clin. Endocrinol. Metab. 96, 3250–3256 (2011)PubMedCrossRef

59.

J.A. Seo, H. Cho, C.R. Eun, H.J. Yoo, S.G. Kim, K.M. Choi, S.H. Baik, D.S. Choi, M.H. Park, C. Han, N.H. Kim, Association between visceral obesity and sarcopenia and vitamin D deficiency in older Koreans: the Ansan Geriatric study. J. Am. Geriatr. Soc. 60, 700–706 (2012)PubMedCrossRef

60.

D.G. Candow, S.C. Forbes, J.P. Little, S.M. Cornish, C. Pinkoski, P.D. Chilibeck, Effect of nutritional interventions and resistance exercise on aging muscle mass and strength. Biogerontology 13, 345–358 (2012)PubMedCrossRef

61.

M. Aubertin-Leheudre, C. Lord, E.D. Goulet, A. Khalil, I.J. Dionne, Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity 14, 2277–2283 (2006)PubMedCrossRef

62.

P. Alexandersen, L.B. Tanko, Y.Z. Bagger, J. Jespersen, S.O. Skouby, C. Christiansen, Associations between aortic calcification and components of body composition in elderly men. Obesity 14, 1571–1578 (2006)PubMedCrossRef

63.

M.A. Schrager, E.J. Metter, E. Simonsick, A. Ble, S. Bandinelli, F. Lauretani, L. Ferrucci, Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. 102, 919–925 (2007)PubMedCentralPubMedCrossRef

64.

Y.S. Kim, Y. Lee, Y.S. Chung, D.J. Lee, N.S. Joo, D. Hong, G.E. Song, H.J. Kim, Y.J. Choi, K.M. Kim, Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the fourth Korean national health and nutritional examination surveys. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1013–1107 (2012)CrossRef

65.

M. Siervo, B.C.M. Stephan, G. Nasti, A. Colantuoni, Ageing adiposity indexes and low muscle mass in a clinical sample of overweight and obese women. Obes. Res. Clin. Pract. 6, e63–70 (2012)

66.

M. Visser, L.M. van Venrooij, L. Vulperhorst, R. de Vos, W. Wisselink, P.A. van Leeuwen, B.A. de Mol, Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr. Metab. Cardiovasc. Dis. (2013) (in press)

67.

T. Schutz, H. Hudjetz, A.E. Roske, C. Katzorke, G. Kreymann, K. Budde, L. Fritsche, H.H. Neumayer, H. Lochs, M. Plauth, Weight gain in long-term survivors of kidney or liver transplantation—another paradigm of sarcopenic obesity? Nutrition 28, 378–383 (2012)PubMedCrossRef

68.

S. Barbat-Artigas, M.E. Filion, S. Plouffe, M. Aubertin-Leheudre, Muscle quality as a potential explanation of the metabolically healthy but obese and sarcopenic obese paradoxes. Metab. Syndr. Relat. Disord. 10, 117–122 (2010)CrossRef

69.

S. Stenholm, D. Alley, S. Bandinelli, M.E. Griswold, S. Koskinen, T. Rantanen, J.M. Guralnik, L. Ferrucci, The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study. Int. J. Obes. 33, 635–644 (2009)CrossRef

Title: Sarcopenic obesity in aging population: current status and future directions for research
Author: Katsuhiko Kohara
Publication date: 01-02-2014
Publisher: Springer US
Published in: Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-013-9992-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Incidentally discovered thyroid nodules: frequency in an adult population during Doppler ultrasonographic evaluation of cervical vessels

Cooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells

Concomitant myasthenia gravis and macroprolactinoma: the immunomodulatory role of prolactin and its potential therapeutic use

Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment

The frequency of malignancy and the relationship between malignancy and ultrasonographic features of thyroid nodules with indeterminate cytology

Traumatic brain injury: endocrine consequences in children and adults

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials